Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional, Open Label, and Randomized Controlled Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Opioid-naive Patients With Moderate to Severe Cancer Pain

NCT03176199 is registered in ClinicalTrials.gov with Taiwan Mundipharma Pharmaceuticals Ltd. as lead sponsor.

NCT NCT03176199
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03176199 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional, Open Label, and Randomized Controlled Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Opioid-naive Patients With Moderate to Severe Cancer Pain
Lead sponsor
Taiwan Mundipharma Pharmaceuticals Ltd.
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2016
Completion date
December 31, 2018
Enrollment
30 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, pain